Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Array Biopharma Inc (ARRY)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Havens Advisors

Nancy Havens-Hasty

109,500 $5,073 3.56%
2. 590,640 $27,364 2.59%
3. 0 $0 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$23.20 5,000 8,000 2019-02-19 Filing
$16.87 3,000 3,000 2018-11-01 Filing
$3.50 28,000 Large Shareholder 19,150,650 2016-09-15 Filing
$3.51 372,000 Large Shareholder 19,129,950 2016-09-14 Filing
$3.19 300,000 Large Shareholder 19,150,650 2016-01-20 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$28.51 100,000 209,543 2019-06-04 Filing
$27.58 36,134 209,543 2019-06-03 Filing
$27.50 15,728 209,543 2019-05-30 Filing
$27.00 74,915 209,543 2019-05-28 Filing
$26.50 40,634 237,692 2019-05-23 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 417,100 $19,324 6.19%
2. 795,712 $36,865 0.68%
3. 100,000 $4,633 0.53%
4. 37,500 $1,737 0.5%
5. 82,500 $3,822 0.47%
News See All